Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2025-12-24 @ 5:30 PM
NCT ID:
NCT02882568
Eligibility Criteria:
Inclusion Criteria:
* between18 and 80 years
* obesity: BMI \> 30
* presumed bacterial infection:
* pneumonitis (documented or probably)
* pyelonephritis / acute prostatitis
* soft tissue / skin infection (except for bedsore)
* cholecystitis / angiocholitis
* meningitis
* clostridium colitis
* surgical site infection
* signed consent
Exclusion Criteria:
* patients with viral, parasitic or mycotic documented infection
* patients with bacterial infection with treatment\> 4 weeks (ex. endocarditis; osteo- articular infections)
* patients with prior antibiotic treatment (\< 14 days)
* intensive care unit patients
* patients with a history of cancer or malignant hematological disease within the 5 previous years that is currently clinically significant (non metastatic prostatic and basocellular malignancy are excluded)
* patients with systemic disease
* Known diagnosis of human immunodeficiency infection (DICV, HIV…)
* immunosuppression treatment during last month including corticotherapy
* pregnancy
* 3 months follow up not possible
* non signed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02882568
Study Brief:
Protocol Section:
NCT02882568